Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.47 USD | -1.22% | -6.37% | -37.25% |
May. 13 | Morgan Stanley Lowers Price Target on NeuroPace to $9.50 From $13, Keeps Equalweight Rating | MT |
May. 08 | NeuroPace, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar NeuroPace, Inc.
Upcoming events on NeuroPace, Inc.
Past events on NeuroPace, Inc.
2024-06-07 01:30 pm | Annual General Meeting |
2024-05-30 09:00 am | Leerink Partners Healthcare Crossroads Conference |
2024-05-28 05:30 pm | Wells Fargo 2024 West Coast MedTech Tour |
2024-05-08 04:30 pm | Q1 2024 Earnings Call |
2024-05-08 04:05 pm | Q1 2024 Earnings Release |
2024-04-08 03:45 pm | Needham Healthcare Conference |
2024-03-05 04:30 pm | Q4 2023 Earnings Call |
2024-03-05 04:05 pm | Q4 2023 Earnings Release |
2024-01-11 10:30 am | JPMorgan Healthcare Conference |
2023-12-02 03:00 pm | American Epilepsy Society Meeting - Exploiting the iEEG |
2023-12-02 02:30 pm | American Epilepsy Society Meeting - Applying Responsive Neuromodulation for Generalized Epilepsies |
2023-12-01 06:30 pm | American Epilepsy Society Meeting - Practical Advice for Building an Advanced Neuromodulation Practi |
2023-11-28 02:30 pm | Piper Sandler Healthcare Conference |
2023-11-06 04:30 pm | Q3 2023 Earnings Call |
2023-11-06 04:03 pm | Q3 2023 Earnings Release |
2023-09-28 01:15 pm | Cantor Global Healthcare Conference |
2023-09-13 | Lake Street Capital Markets Big7 Conference |
2023-09-13 09:30 am | Morgan Stanley Global Healthcare Conference |
2023-09-06 | Wells Fargo Healthcare Conference |
2023-08-08 04:30 pm | Q2 2023 Earnings Call |
Annual results
Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 41,1 | 45,2 45,1 0.11% | 45,5 45,5 0.02% | 65,4 65,1 0.54% | 75,9 |
EBITDA Million USD | Released Forecast Spread | 0,00 | -23,4 -20,2 -16.13% | -32,2 -37,0 13.15% | -17,4 -23,4 25.3% | -20,2 |
EBIT Million USD | Released Forecast Spread | 0,00 | -23,7 -21,0 -13.09% | -40,8 -41,7 2.08% | -27,2 -29,2 6.9% | -27,1 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -36,1 -34,0 -6.12% | -47,1 -48,3 2.59% | -33,0 -34,8 5.37% | -33,2 |
Net income Million USD | Released Forecast Spread | -24,3 | -36,1 -33,6 -7.44% | -47,1 -48,6 3.12% | -33,0 -34,9 5.49% | -33,1 |
EPS USD | Released Forecast Spread | -45,3 | -2,17 -1,81 -19.89% | -1,91 -1,96 2.75% | -1,27 -1,35 6.17% | -1,16 |
Announcement Date | 24/03/21 | 10/03/22 | 02/03/23 | 05/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 11,4 10,8 5.67% | 10,2 11,1 -7.94% | 11,2 10,0 11.57% | 12,8 12,8 -0.05% | 14,5 12,2 18.94% | 16,5 12,6 30.77% | 16,4 14,2 15.5% | 18,0 17,7 1.49% | 18,1 17,3 4.75% | 18,3 | 18,8 | 20,7 | 21,4 | 21,2 |
EBITDA Million USD | Released Forecast Spread | -8,19 -6,54 -25.25% | -8,30 -8,30 -0.03% | -7,96 -10,0 20.43% | -7,73 -8,73 11.5% | -6,15 -8,37 26.54% | -5,15 -9,20 44.01% | -3,49 -7,57 53.84% | -2,65 -5,10 47.96% | -4,96 -5,73 13.49% | -5,43 | -4,63 | -4,13 | -6,00 | -6,00 |
EBIT Million USD | Released Forecast Spread | -9,76 -8,67 -12.63% | -11,0 -9,48 -15.7% | -10,2 -11,5 11.66% | -9,86 -10,6 7.41% | -8,32 -9,92 16.17% | -7,85 -10,4 24.39% | -5,95 -9,12 34.76% | -5,05 -6,94 27.24% | -7,55 -7,91 4.67% | -7,51 | -6,69 | -5,59 | -6,00 | -6,00 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -11,5 -12,0 4.49% | -12,7 -11,0 -15.36% | -11,8 -13,0 9.35% | -11,1 -12,4 9.87% | -10,4 -10,9 4.52% | -9,12 -12,0 24.18% | -7,26 -10,4 30.22% | -6,20 -7,93 21.77% | -8,93 -8,90 -0.28% | -8,55 | -8,28 | -7,40 | -7,00 | -8,00 |
Net income Million USD | Released Forecast Spread | -11,5 -10,6 -8.63% | -12,7 -11,1 -14.38% | -11,8 -13,1 9.96% | -11,1 -12,4 10.43% | -10,4 -10,9 4.89% | -9,12 -11,8 22.55% | -7,26 -10,5 30.96% | -6,20 -8,09 23.36% | -8,93 -8,90 -0.33% | -8,62 | -8,13 | -7,41 | -8,66 | -8,83 |
EPS USD | Released Forecast Spread | -0,47 -0,43 -8.68% | -0,52 -0,45 -14.46% | -0,48 -0,54 10.78% | -0,45 -0,50 9.55% | -0,41 -0,45 7.87% | -0,36 -0,47 22.73% | -0,28 -0,41 31.45% | -0,23 -0,31 25.19% | -0,32 -0,32 0.98% | -0,31 | -0,28 | -0,26 | -0,31 | -0,30 |
Announcement Date | 12/05/22 | 11/08/22 | 08/11/22 | 02/03/23 | 04/05/23 | 08/08/23 | 06/11/23 | 05/03/24 | 08/05/24 | - | - | - | - | - |
Past sector events for NeuroPace, Inc.
2024-06-05 01:30 am | ELEKTA AB: Q4 2024 Earnings Release |
2024-05-29 04:05 pm | AGILENT TECHNOLOGIES, INC.: Q2 2024 Earnings Release |
2024-05-14 | FUKUDA DENSHI CO., LTD.: Q4 2023 Earnings Release |
2024-05-12 | NIHON KOHDEN CORPORATION: Q4 2023 Earnings Release |
2024-05-09 | OLYMPUS CORPORATION: Q4 2024 Earnings Release |
2024-05-08 04:05 pm | CYTEK BIOSCIENCES, INC.: Q1 2024 Earnings Release |
2024-05-08 04:01 pm | STANDARD BIOTOOLS INC.: Q1 2024 Earnings Release |
2024-05-08 01:00 am | CARL ZEISS MEDITEC AG: Q2 2024 Earnings Release |
2024-05-07 | CLASSYS INC.: Q1 2024 Earnings Release |
2024-05-07 04:00 pm | QUANTERIX CORPORATION: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NPCE Stock
- Calendar NeuroPace, Inc.